GRK5 is the best-characterized member of the GRK4 dress the physiological importance of GRK5-mediated subfamily of GRKs, which also contains GRK4 and GRK6 regulation of GPCRs, mice bearing targeted deletion (Premont et al., 1995). The GRK5 mRNA is expressed of the GRK5 gene (GRK5-KO) were generated. GRK5-widely in brain and peripheral tissues, with the highest KO mice exhibited mild spontaneous hypothermia as expression evident in heart, lung, and placenta; howwell as pronounced behavioral supersensitivity upon ever, the expression pattern of the GRK5 protein is challenge with the nonselective muscarinic agonist not well characterized. In model systems, GRK5 has oxotremorine. Classical cholinergic responses such been shown to be able to phosphorylate several disas hypothermia, hypoactivity, tremor, and salivation tinct GPCR types, including rhodopsin, ␤ 2 -adrenergic, were enhanced in GRK5-KO animals. The antinocicep-M 2 -muscarinic, secretin, endothelin ET 1 , angiotensin tive effect of oxotremorine was also potentiated and pro- loxP sites, leaving a deleted GRK5 gene (GRK5-KO) with
To examine the function of GRK5, the mouse GRK5 Many important neuromodulators function through actigene was inactivated by homologous recombination. vation of specific pre-and postsynaptic G proteinMice lacking functional GRK5 were then assessed for coupled receptors (GPCRs). These include the adrenertheir ability to adapt when challenged with GPCR agogic, muscarinic, serotonergic, and dopaminergic systems, nists. Strikingly, these animals are supersensitive to as well as a great variety of peptidergic systems. Binding challenge with the muscarinic agonist oxotremorine, of such substances to their specific cell surface recepand display an apparent lack of desensitization of mustors leads to activation of the intracellular G proteincarinic receptor responsiveness. mediated effector pathways, such as adenylyl cyclase, phospholipase C-␤, or various ion channels, which then Results alter neuronal responsiveness (Dickey and Birnbaumer, 1993). One notable feature of these G protein pathways Generation of GRK5-KO Mice is that the cell surface receptors are subject to precise To begin to address the functions of GRK5 in vivo, the regulation of their sensitivity. Prolonged or repeated ex-GRK5 gene was targeted by homologous recombination posure of a receptor to its agonist leads to diminished in embryonic stem (ES) cells, as shown in Figure 1A . responsiveness of the receptor to further stimulation, or
The targeting construct introduced two loxP sites into desensitization (Hausdorff et al., 1990) . the gene, flanking exons 7 and 8, as well as a selectable marker gene cassette also flanked by loxP sites. Transient transfection of a targeted ES cell clone with cre § To whom correspondence should be addressed (e-mail: lefko001@ recombinase led to loss of the sequences between the receptor-biol.duke.edu). These authors contributed equally to this work.
loxP sites, leaving a deleted GRK5 gene (GRK5-KO) with (Lomax, 1970) . Muscarinic agonist GRK5-KO gene contains intact exons 1-6, and could treatment produces rapid and profound hypothermia, potentially produce a transcript encoding amino acids and this response has been used classically to assess 1-178, but exon 9 would be spliced out of frame and lead muscarinic receptor sensitivity in vivo (Dilsaver and to termination after the addition of 16 novel residues. Alessi, 1988). In light of the subtle differences in core Proper targeting of the GRK5 gene, and subsequent temperatures, we challenged mice with the nonselective animal genotyping, was assessed using triplex polymermuscarinic agonist oxotremorine (Gomeza et al., 1999) ase chain reaction (PCR) amplification ( Figure 1B) . Westto assess potential changes in hypothermic parameters ern blot analysis of GRK5 protein expression in brain in the GRK5-KO mice. In this paradigm, the GRK5-KO membranes reveals the presence of GRK5 immunoreacmice exhibited a more pronounced and longer lasting tivity in wild-type mice but not in the GRK5-KO animals depression in body temperature than did wild-type con-( Figure 1C ). The upper band may represent the GRK4 trol mice (Figure 2A ). In contrast, central hypothermic or GRK6 subtypes that are also recognized by this responses to the serotonin 5-HT1A receptor agonist monoclonal antibody.
8-OH-DPAT (Overstreet et al., 1998) did not differ between genotypes ( Figure 2B ).
Initial Characterization of GRK5-KO Mice
It is well established that activation of central muscaThe homozygote GRK5-KO mice are viable and present rinic pathways results in a characteristic set of manifesno gross anatomical differences nor striking behavioral tations, known as cholinergic syndrome. Figure 3B ) and more potent and longer lasting depression of horizontal cocaine (data not shown) also did not differ between activity in mutant versus wild-type mice ( Figure 3A) . No-GRK5-KO and littermate controls. The only intrinsic diftably, the dopamine receptor agonist, apomorphine, ference detected between untreated GRK5-KO and produced similar climbing responses in both genotypes wild-type animals was in core body temperature, which ( Figure 3B ). Further, mice challenged with oxotremorine was ‫9.0ف‬ЊC lower in GRK5-KO mice (basal core temperexhibited increased and prolonged tremor ( Figure 4A ) ature was 37.3 Ϯ 0.09ЊC , n ϭ 30, in wild-type animals and 36.4 Ϯ 0.1ЊC, n ϭ 28, in GRK5-KO mice).
and salivation ( Figure 4B ). Thus, GRK5-KO mice exhibit To test whether the observed behavioral supersensitivity of GRK5-KO mice is reflective of altered muscarinic receptor signaling, and does not represent altered pharmacokinetic or pharmacodynamic properties of oxotremorine, we also treated mice with physostygmine, which raises endogenous acetylcholine levels by inhibiting acetylcholinesterase (Galeotti et al., 1996). Physostygmine (0.2 mg/kg, intraperitoneally [i.p.]) produced significant analgesia in both GRK5-KO and wild-type mice, but continued to invoke analgesia in GRK5-KO mice even 90 min after injection, by which time the responsiveness of wild-type mice had returned to basal levels (data not shown). These studies reveal that regardless of the means of receptor stimulation, either suggests that there may be changes in either neuronal (Table 1) .
where the desensitization of muscarinic receptors was Potential changes in receptor sensitivity were asinduced in animals by systemic treatment with 0.5 mg/ sessed indirectly by measuring receptor coupling to G kg oxotremorine (i.p.) 30 min before sacrifice and prepaproteins. In this approach, freshly dissociated brain ration of striatum membranes (data not shown). By comstem pieces were pre-exposed to millimolar concentraparison, isoproterenol-stimulated binding of [ 
1990). However, the apparent inet al., 1998). However, previously it has not been deterability of brain muscarinic receptors to desensitize in mined whether this will result in enhanced receptor re-GRK5-KO animals argues that such compensation is sponsiveness in vivo or which receptor populations are minimal. Further, no obvious increases in the levels of affected. The present observations unequivocally demother GRKs in the brain are apparent by Western blotting onstrate that not only are muscarinic receptors resistant (data not shown). to desensitization in the GRK5-KO mouse, but they also
Behavioral analyses were performed after challenging appear to be supersensitive to muscarinic agonists.
animals with a number of agonists to seek out the speFrom initial characterization of the GRK5-KO mice, it cific receptors affected by the loss of GRK5. Remarkbecame evident that under basal, unchallenged condiably, we found no differences in cocaine-induced locotions, these mice demonstrate a very modest phenomotor responses and climbing responses following high type, because only a slight decrease in body temperadoses of apomorphine, a direct D1/D2 dopamine recepture was found. This observation of a weak phenotype tor agonist ( siveness subsequent to impaired desensitization of M2 muscarinic receptors. However, these data do not prethe impairment of GRK-mediated desensitization may contribute to the altered responsiveness of the recepclude the possibility that other muscarinic receptors tors involved in these conditions, such as dopamine and and/or other GPCRs could be affected in these mice. opioid receptors. In addition, since M2 receptors are abundant in the carIn summary, GRK5-KO mice demonstrate marked bediovascular system, future studies in these animals havioral supersensitivity to muscarinic agonist stimulashould be useful to evaluate the role of GRK5 in controltion. Importantly, the observed behavioral supersensiling cardiac responses. tivity is correlated with an apparent lack of muscarinic Six GRKs have been identified to date, while more receptor desensitization in functional biochemical assays. than 1500 GPCRs have already been cloned (Pitcher et These data demonstrate, in an in vivo animal model, al., 1998). Thus, redundancy in the mechanisms of GPCR that GRK5-mediated regulation of GPCR signaling is regulation, such as the involvement of one GRK in the physiologically relevant and that muscarinic receptors phosphorylation of multiple receptors, is to be expected. are likely in vivo targets for this kinase. However, the large effect seen in muscarinic responsiveness in the GRK5-KO animals argues that remark- 
